Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cosmo Pharmaceuticals NV
F:C43
Cosmo Pharmaceuticals NV
F:C43
Price:
54.5
EUR
-1.98%
Market Closed
Market Cap:
€876.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cosmo Pharmaceuticals NV
F:C43
|
IE |
|
R
|
Rank Group PLC
F:RNKA
|
UK |
|
C
|
Cathay Pacific Airways Ltd
F:CTY
|
HK |
|
N
|
Newpeak Metals Ltd
F:NPM
|
AU |
|
S
|
Sonic Automotive Inc
F:SA8A
|
US |
|
Ryvyl Inc
NASDAQ:RTB
|
US |
|
P
|
Pexip Holding ASA
XMUN:4W9
|
NO |
|
M
|
Matsa Resources Ltd
XMUN:KB2
|
AU |
|
Trip.com Group Ltd
F:CLVB
|
SG |
|
A
|
Andritz AG
DUS:AZ2
|
AT |
|
NeuroScientific Biopharmaceuticals Ltd
ASX:NSB
|
AU |
|
Stanmore Resources Ltd
F:S0D
|
AU |
|
K
|
Kohls Corp
F:KHP
|
US |
Wall St Price Targets
C43 Price Forecast
Based on 9 analysts
Based on 9 analysts
+199% Upside
from
€54.5
today
Cosmo Pharmaceuticals NV (C43)’s 12-month stock price forecast through October 2027 has a consensus target of €163.16, implying 199% upside. The forecast is based on price targets from 9 Wall Street analysts.
C43 Analyst Rating
No ratings yet
No ratings yet
Cosmo Pharmaceuticals NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C43's stock price target?
Price Target
163.16
EUR
163.16
EUR
According to Wall Street analysts, the average 1-year price target for C43 is 163.16 EUR with a low forecast of 112.39 EUR and a high forecast of 233.68 EUR.
What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
38%
38%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 38%.
What is the Gross Profit forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
44%
44%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 44%.